Research notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Mix and margin benefits = strong growth

Orica
3:27pm
May 8, 2025
ORI’s 1H25 result was strong and beat consensus EBIT and NPAT by 5.4% and 9.7% respectively. Underlying EBIT, NPAT, EPS and DPS all increased 34%/40%/33%/32% on the pcp. ORI is on track to report strong growth for the full year and has also provided positive outlook commentary for FY26. We have made minor upgrades to our forecasts which were previously above consensus estimates. With leverage to attractive industry fundamentals, market leading positions, strong earnings growth, proven management team and strong balance sheet, we think ORI’s trading multiples are undemanding and reiterate our Add rating.

Diversity kicks in

Super Retail Group
3:27pm
May 8, 2025
SUL’s trading update was slightly softer, but generally better-than-feared as strength in BCF/rebel offset weaker contributions from SCA/Macpac. We are encouraged by the evidence of stability within SCA through April, sustained sales strength of BCF (+8.3% in FY25); ongoing positive momentum within rebel; and continued investment through the cycle (distribution, store network, systems). We view the LT investment case intact and discount to peers unwarranted. Add.

Well-funded to advance programs

Syntara
3:27pm
May 8, 2025
Quarterly operational cash use of A$3.5m declined 35% on pcp, with staff costs down 26%, but R&D up 9%. Lead drug candidate SNT-5505 targeting bone cancer myelofibrosis is expected to report Phase 2 interim data at a medical conference in Jun-25. The skin scarring program has shown biological and structural normalisation of established scars, similar to normal, uninjured skin for SNT-6302, while next-generation topical SNT-9465 will enter Phase 1a/b testing this quarter. Phase 2a recruitment for SNT-4728 in Isolated REM Sleep Behaviour Disorder (iRBD) should accelerate with the opening of a UK site, with full enrollment expected by YE25 subsequent to data 1H26. The company sits on A$18m in cash, giving more than 5 quarters of runway at current burn.

1H25: M&T spike and cost skew mask softer result

National Australia Bank
3:27pm
May 7, 2025
1H25 earnings beat expectations but was supported by lower quality elements. We believe higher dividends and new buybacks are unlikely due to an approaching CET1 capital constraint. 0-2% upgrades to FY25-27F EPS as we assume lower NIM, opex, and cost of risk than previously, but also note our terminal forecasts decline as we capture a lower interest rate environment than previously assumed. 12 month target price hence reduces c.4% to $28.01/sh. With a 12 month potential TSR of -17% (incl. 4.7% cash yield) at current prices we continue to rate NAB a REDUCE.

Diversified compounder with acquisitive growth

SRG Global
3:27pm
May 7, 2025
We initiate coverage of SRG Global (SRG) with an ADD and $1.80 target price. SRG is an Australian diversified infrastructure services company that provides maintenance, industrial services, and engineering and construction services across >20 industries including mining, water, energy, infrastructure and utilities. SRG has a track record of delivering strong and consistent EPSA growth (+33% CAGR from FY21-24) through a combination of organic sales growth, margin expansion and acquisitions. Customer preference towards specialist maintenance providers (vs generalists), coupled with a significant increase in production volumes for key gold mining customers, should ensure that strong organic growth continues. Organic growth will be supplemented by a prudent acquisition strategy (net cash). At 13x FY25F PE, this is not being factored into the share price.

Solid quarter, albeit growth has slowed

JB Hi-Fi
3:27pm
May 7, 2025
JB Hi-Fi reported a solid 3Q25 trading update, which saw positive sales growth across all divisions, albeit growth has slowed in February/ March compared to the first 4 weeks of the quarter. Whilst no comments were made on margins or April trading in the release, management have noted that the retail environment remains challenging and competitive. We have made minor revisions to our earnings and our valuation remains unchanged. We have a HOLD recommendation with a $92 price target.

Mark-to-market changes impact FY25F earnings

HMC Capital
3:27pm
May 7, 2025
HMC’s FY25F earnings continue to be adversely impacted by fair value movements across a number of its investment holdings (HMCCP and financial assets). These non-cash mark-to-market changes see the business delivering FY25 annualised NPBT (per share) of 66c. Whilst financial markets remain volatile, the drawdowns across HMC’s healthcare and digital strategies have seen an outsize movement in the HMC share price (noting that few listed fund managers have escaped the negative share price performance CYTD). At c.46c of recurring NPBT (per share) in FY26, HMC is trading on c.14.5x (PER) – a multiple which reflects investor conservatism around management’s capacity to grow FUM at the implied target rate of 22% to 40%pa over the next three to five years. Given that HMC’s share price will likely follow the trajectory of the underlying funds, we prefer to play the HMC turnaround through its funds, be it DGT or HDN. On this basis, we retain our Hold rating with a $5.20/sh price target.

The first AI in AU

NEXTDC
3:27pm
May 6, 2025
Yesterday we published a note reviewing quarterly results from the US Megatech companies. This showed end customer demand for Cloud and AI and consequently capex for data centres continued to rise. Today NXT proved this point in announcing it had secured a 50MW hyperscale AI deal in its Melbourne facility. This was broadly in line with our expectations and we consequently make immaterial changes to our forecasts. Add recommendation and $18.80 target price retained.

Look at the big picture

IMDEX
3:27pm
May 6, 2025
The 3Q revenue update was a bit weaker than expected as constant FX revenue fell slightly against 2Q, and the FX tailwind wasn’t as material as forecasted. This has seen a 2% downgrade to our FY25 EBITDA. However, to our mind, the cadence of sensor volumes (-3% at 1H25 to +1% during 3Q and more recently +4%) is the clearest indication that the cycle has reached a positive inflection point. This, coupled with our understanding of the key leading indicators, increases our confidence in the company’s growth prospects beyond FY25. As such, changes to outer year forecasts are de minimis and our target price is unchanged ($3.20).

US deal sends DXB to new heights

Dimerix
3:27pm
May 6, 2025
DXB announced it has secured an exclusive licensing transaction in the United States with Nasdaq listed US$2bn rare disease player Amicus Therapeutics (FOLD.NAS). The licence includes a US$30m (A$48m) upfront payment and US$560m in milestone payments along with tiered royalties on net US sales. The deal shortly followed DXB’s announcement of a positive Type-C meeting with the FDA confirming the measure of proteinuria can be used as an approvable endpoint for FSGS.  The deal marks the fourth licensing transaction for DXB for its DMX-200 asset which is currently in Ph3 trials. Key upcoming catalyst is the Part 2 (n=144) readout of its Ph3 trial around August, which, pending results has potential to apply for conditional approval.

News & insights

In recent days, several people have asked for my updated view on the Federal Reserve and the Fed funds rate, as well as the outlook for the Australian cash rate. I thought I’d walk through our model for the Fed funds rate and explain our approach to the RBA’s cash rate.

In recent days, several people have asked for my updated view on the Federal Reserve and the Fed funds rate, as well as the outlook for the Australian cash rate. I thought I’d walk through our model for the Fed funds rate and explain our approach to the RBA’s cash rate.

It’s fascinating to look at the history of the current tightening cycle. The Fed began from a much higher base than the RBA, and in this cycle, they reached a peak rate of 535 basis points, compared to the RBA’s peak of 435 basis points. For context, in the previous tightening cycle, the RBA reached a peak of 485 basis points.

The reason the RBA was more cautious this time around is largely due to an agreement between Treasurer Jim Chalmers and the RBA. The goal was to implement rate increases that would not undo the employment gains made in the previous cycle. As a result, the RBA was far less aggressive in its approach to rate hikes.

This divergence in peak rates is important. Because the Australian cash rate peaked lower, the total room for rate cuts and the resulting stimulus to the economy is significantly smaller than in previous cycles.

The Fed, on the other hand, peaked at 535 basis points in August last year and began cutting rates shortly after. By the end of December, they had reduced the rate to 435 basis points, where it has remained since.

Recent U.S. labour market data shows a clear slowdown. Over the past 20 years, average annual employment growth in the U.S. has been around 1.6 percent, but this fell to 1.0 percent a few months ago and dropped further to 0.9 percent in the most recent data.

This suggests that while the Fed has successfully engineered a soft landing by slowing the economy, it now risks tipping into a hard landing if rates remain unchanged.

Fed Funds Rate Model Update

Our model for the Fed funds rate is based on three key variables: inflation, unemployment, and inflation expectations. While inflation has remained relatively stable, inflation expectations have declined significantly, alongside the drop in employment growth.

As a result, our updated model now estimates the Fed funds rate should be around 338 basis points, which is 92 basis points lower than the current rate of 435. This strongly suggests we are likely to see a 25 basis point cut at the Fed’s September 17 meeting.

There are two more Fed meetings scheduled for the remainder of the year, one in October and another on December 10. However, we will need to review the minutes from the September meeting before forming a view on whether further cuts are likely.

Australian Cash Rate Outlook

Turning to the Australian cash rate, as mentioned, the peak this cycle was lower than in the past, meaning the stimulatory effect of rate cuts is more limited.

We have already seen three rate cuts, and the key question now is whether there will be another at the RBA’s 4 November meeting.

This decision hinges entirely on the September quarter inflation data, which will be released on 29 October 2025.

The RBA’s strategy is guided by the concept of the real interest rate. Over the past 20 years, the average real rate has been around 0.85 percent. Assuming the RBA reaches its 2.5 percent inflation target, this implies a terminal cash rate of around 335 basis points. Once that level is reached, we expect it will mark the final rate cut of this cycle, unless inflation falls significantly further.

So, will we see a rate cut in November?

It all depends on the trimmed mean inflation figure for the September quarter. If it comes in at 2.5 percent or lower, we expect a rate cut. The June quarter trimmed mean was 2.7 percent, and the monthly July figure was 2.8 percent. If the September figure remains the same or rises, there will be no cut. Only a drop to 2.5 percent or below will trigger another move.

We will have a much clearer picture just a few days before Melbourne Cup Day.

Read more
The Wall Street Journal of 21 August 2025 carried an article which noted that Ether, a cryptocurrency long overshadowed by Bitcoin has surged in price in August

The Wall Street  Journal of 21 August 2025 carried an article which noted that Ether, a cryptocurrency long overshadowed by Bitcoin has surged in price in August.

The article noted that unlike Bitcoin, there was not a hard cap on Ether supply, but the digital token is increasingly used for transactions on Ethereum , a platform where developers build and operate applications that can be used to trade, lend and borrow digital currencies.

This is important  because of the passage on 18 July 2025 of the GENIUS act which creates the first regulatory framework for Stablecoins. Stablecoins are US Dollar pegged digital tokens. The Act requires  that  Stablecoins , are to be to be fully  backed by US Treasury Instruments  or other  US dollar assets .

The idea is that if Ethereum becomes part of the infrastructure of Stablecoins , Ether would then benefit from increased activity on the Ethereum platform.

Tokenized money market funds from Blackrock and other institutions already operate on the Ethereum network.

The Wall Street journal  article  goes on to note that activity on the Ethereum platform has already amounted to more than $US1.2  trillion this year ,compared with $960 million to the same period last year.

So today ,we thought it might be a good idea to try and work out what makes Bitcoin and Ether  go up and down.

As Nobel Prize winning economist  Paul Krugman once said "  Economists don't care if a Model works in practice ,as long as it works in theory" .  Our theoretical model might be thought as a "Margin Lending Model" . In such a model variations in Bitcoin are a function of variation in the value of the US stock market .

As the US stock market rises, then the amount of cash at margin available to buy Bitcoin also rises .

The reverse occurs when the US stock market goes down .

Our model of Bitcoin based on this theory is shown in Figure 1  .  We are surprised that this simple model explains 88% of monthly variation  in Bitcoin since the beginning of 2019.

Figure 1 - BTC

At the end of August  our model  told us that when Bitcoin was then valued at $US112,491 , that it was then overvalued by $US15,785 per token.

Modeling Ether is not so simple . Ether is a token but Ethereum is a business.  this makes the price of Either sensitive to variations in conditions in the US Corporate Debt Market.

Taking that into account as well as stock market strength, gives us a model for Ether which is shown in figure 2.


Figure 2- Ethereum


This model explains 70.1% of monthly variation since the beginning of 2019. Our model tells us that at the end of August, Ether at $US 4,378per token was $US 560 above our model estimate of $US3,818.00 . Ether is moderately overvalued.

So neither  Bitcoin nor Ether are cheap right now.

ETFs for each of Bitcoin and Ether are now available from your friendly local stockbroker .

But right now , our models tell us that neither of them is cheap!

Read more
Uncover insights from Jackson Hole: Jay Powell’s rate cut hints, Fed’s soft landing concerns, and dire demographic trends. Analysis by Morgans’ Chief Economist.


There is more to what happened at Jackson Hole than just the speech by Jay Powell.

In my talk last week ,I said that our model of the Fed funds rate stood at 3.65%. This is actually 70 basis points lower than the actual  level of 4.35%.

I also said that the Fed was successfully achieving a "soft landing" with employment growing at 1%. This was below the median level of employment growth  since 2004 of 1.6%.

Still , as I listened to Jay Powell Speak , I noted a sense of concern in his voice when he said that "The July employment report released earlier this month slowed to an average pace of only 35,000 average per month over the past three months, down from 168,000 per month during 2024. This slowdown is much larger than assessed just a month ago."

My interpretation of this is that Chair Powell may be concerned that the "soft landing " achieved by the Fed may be in danger of turning into a "hard landing". This suggested a rate cut of 25 basis points by the Fed at the next meeting on 17-18 September.

This would leave the Fed Funds rate at 4.1%. This would mean that the Fed Funds rate would still be 45 basis points higher than our model estimate of 3.65%. Hence the Fed Funds rate would remain "modestly restrictive."

Dire Demography?

Jackson Hole was actually a Fed Strategy meeting with many speakers in addition to Jay Powell.

Two speakers who followed on the  afternoon of his speech were Claudia Goldin, Professor at Harvard

and Chad Janis of Stanford Graduate Business School. They each gave foreboding presentations on the demography of developed economies.

Claudia Goldin spoke on "The Downside of Fertility".  She noted that birth rates in the Developed World are now generally  below replacement level. The Total Fertility rate is below 2 in France , the US and the UK.

It is dangerously low below 1.5 in Italy and Spain and below 1 in Korea. She observes that the age of first marriage of couples  in the US is now 7 years later than it was in the 1960's. This reduces  their child bearing years.

This paper was then followed by a discussion of it by Chad Janis of Stanford Graduate Business School. He noted that there is a profound difference between a future with a replacement rate of 2.2 kids per family , which he called  the "Expanding Cosmos"  with

•   Growing population leading to a growing number of researchers, leading to rising living standards  and Exponential growth in both living standards and population AND a replacement level of 1.9 kids per family which leads to  

•   Negative population growth , which he called "an Empty Planet " and the end of humanity

 as numbers of researchers declines and economic growth ceases.

Of course this seems all  very serious indeed .  Perhaps what this really means ,is that  if  we want to save the world , we should just relax and start having a lot more fun!!

Read more